Vector Y Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS (NCT07287397) | Vector Y Therapeutics | 2025-12-19 |
Track Vector Y Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.